Navigation Links
Drug Stops Herpes

A new study shows the drug valacyclovir may significantly reduce the spread of the genital herpes virus. Researchers studied more than 1,400 heterosexual couples. In each case, one partner was diagnosed with //type 2 herpes and the other was susceptible to the virus. Type 2 herpes causes a chronic genital viral infection and is often contagious.

Participants with herpes were given either 500 milligrams of valacyclovir once a day or a placebo for eight months. Susceptible partners were evaluated monthly for symptoms of the virus. Both partners were counseled on safe sex and were offered condoms at each visit.

Results of the study show only four out of 743 of the susceptible partners who were given the drug developed clinically symptomatic herpes. However, 16 out of 741 participants who were given a placebo developed the virus. Overall, type 2 herpes was observed in 14 of the susceptible partners who received valacyclovir and 27 of the partners who received a placebo.

Researchers say transmission of genital herpes to others is the chief concern in patients with the virus. Authors conclude, "Our study demonstrates that oral valacyclovir taken by immunocompetent persons with recurrent genital HSV-2 infection significantly reduces the rates of HSV reactivation, subclinical shedding, and transmission of genital herpes to a susceptible partner.


'"/>




Page: 1

Related medicine news :

1. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
2. Satyam Stops Conducting HIV Tests On Employees To Prevent Discrimination
3. High Court Stops Functioning of Ayurvedic, Unani Colleges in Uttar Pradesh
4. Japan Stops Import of Poultry from S. Korea
5. Starbucks Stops Using Dairy Products Containing RBGH
6. Chinese Medicinal Compound Stops Formation of Cysts in Polycystic Kidney
7. Drug Found To Reduce The Transmission Of Herpes
8. Cancer Causing Herpes Virus At Last May Have A Cure
9. Treating Latent Herpes With Licorice
10. Experts Insist That Neonatal Herpes Be Reported Regularly
11. FDA to Revise Herpes Test Rules in the US
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
Breaking Medicine Technology: